Vanda Pharmaceuticals Inc. (VNDA) Balance Sheet
As of 2026-06-30 (10-Q), Vanda Pharmaceuticals Inc. (VNDA) reported total assets of $412.5M, total liabilities of $192.3M and shareholders' equity of $220.2M, according to EquiReason's reading of its SEC filings. Cash and equivalents: $55.9M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
VNDAVanda Pharmaceuticals Inc.Follow VNDA — free
—
Price chart with a free account
- Market cap
- 242.5M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 28 Oct, in 4 days
| Line | FY2011 Dec 11 | FY2012 Dec 12 | FY2013 Dec 13 | FY2014 Dec 14 | FY2015 Dec 15 | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | Latest Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 87.9 | 88.8 | 64.8 | 60.9 | 50.8 | 40.4 | 33.6 | 61.0 | 45.1 | 61.0 | 52.1 | 135.0 | 135.8 | 102.3 | 84.9 | 55.9 | |
| Short-term investments | 61.0 | 31.6 | 65.6 | 68.9 | 92.3 | 100.9 | 109.8 | 196.4 | 267.1 | 306.7 | 380.7 | — | — | — | — | — | |
| Receivables | 1.6 | 1.2 | 2.0 | 3.7 | 16.3 | 20.3 | 17.6 | 28.8 | 26.4 | 30.0 | 32.5 | 33.5 | 34.2 | 47.1 | 54.6 | 59.7 | |
| Inventory | — | 0.1 | — | 5.2 | 1.3 | 0.8 | 0.8 | 1.0 | 1.1 | 1.3 | 1.0 | 1.2 | 1.4 | 1.7 | 1.9 | 1.7 | |
| Current assets | 153.5 | 126.0 | 135.6 | 141.7 | 166.5 | 174.2 | 169.9 | 299.1 | 354.1 | 409.1 | 478.3 | 519.3 | 432.9 | 438.9 | 347.3 | 264.5 | |
| Total assets | 182.6 | 135.4 | 143.3 | 171.7 | 213.1 | 210.4 | 205.4 | 332.1 | 483.7 | 533.5 | 593.8 | 634.2 | 648.4 | 656.2 | 488.9 | 412.5 | |
| Current liabilities | 31.6 | 32.3 | 32.9 | 7.8 | 51.3 | 50.3 | 70.4 | 53.0 | 59.5 | 65.9 | 74.4 | 91.4 | 87.7 | 100.0 | 145.2 | 164.0 | |
| Total liabilities | 149.1 | 125.5 | 99.2 | 10.9 | 80.0 | 79.0 | 74.0 | 56.7 | 72.8 | 80.2 | 88.9 | 107.0 | 103.5 | 117.7 | 161.8 | 192.3 | |
| Shareholders' equity | 33.5 | 9.9 | 44.1 | 160.8 | 133.0 | 131.3 | 131.4 | 275.4 | 410.9 | 453.3 | 504.9 | 527.2 | 544.9 | 538.5 | 327.2 | 220.2 |
USD millions · SEC XBRL
Vanda Pharmaceuticals Inc. — questions
- How much cash does Vanda Pharmaceuticals Inc. have?
- $55.9M in cash and cash equivalents as of 2026-06-30.
- What are Vanda Pharmaceuticals Inc.'s total assets?
- $412.5M as of 2026-06-30.
- What is Vanda Pharmaceuticals Inc.'s shareholders' equity?
- $220.2M as of 2026-06-30.
Every figure on this page comes from Vanda Pharmaceuticals Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.